ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Radiation Oncology

Cardiac Radiation Dose, Cardiac Events, and Survival in Locally Advanced NSCLC

Megan Daly
on: October 19, 2020In: Radiation Oncology
Cardiac Radiation Dose, Cardiac Events, and Survival in Locally Advanced NSCLC

Megan Daly The standard of care for fit patients with unresectable, locally advanced (LA-) NSCLC is concurrent chemoradiation (CRT) followed by consolidation durvalumab. However, thoracic radiation (RT) for lung cancer […] Read more


Brain Metastases in NSCLC: Is Delaying Upfront Radiation a Viable Option?

on: August 18, 2020In: Radiation Oncology
Brain Metastases in NSCLC: Is Delaying Upfront Radiation a Viable Option?

By Arya Amini, MD, and Chad G. Rusthoven, MD Posted: August 19, 2020 Approximately 10% of patients diagnosed with metastatic NSCLC present with brain metastases, and another 30% develop brain […] Read more

PCI Decreases the Risk of Brain Metastases in Patients with Locally Advanced NSCLC

on: May 26, 2019In: Radiation Oncology
PCI Decreases the Risk of Brain Metastases in Patients with Locally Advanced NSCLC

By Elizabeth Gore, MD Posted: May 27, 2019 IN REFERENCE TO: De Ruysscher D, Dingemans AC, Praag J, et al. Prophylactic cranial irradiation versus observation in radically treated stage III non-small-cell […] Read more

Prophylactic Cranial Irradiation in Locally Advanced NSCLC Falls Flat

on: December 12, 2018In: Radiation Oncology
Prophylactic Cranial Irradiation in Locally Advanced NSCLC Falls Flat

By John Armstrong, MD, FRCPI, DABR, FFRRCSI Posted: December 2018 RTOG 0214, a phase III randomized trial, is the biggest trial to date testing prophylactic cranial irradiation (PCI) in locally […] Read more

2018 ASTRO Guideline for Palliative Thoracic Radiation Therapy for NSCLC: The Balance Between Curative and Palliative Radiotherapy

on: November 08, 2018In: Radiation Oncology
2018 ASTRO Guideline for Palliative Thoracic Radiation Therapy for NSCLC: The Balance Between Curative
            and Palliative Radiotherapy

By Shalini K. Vinod, MBBS, MD Posted: October 2018 The standard of care for patients with inoperable stage III NSCLC is curative radiotherapy and concurrent chemotherapy.1 However, there are numerous […] Read more

Living in the “Gray Zone”: Entering a New Age in Radiation Therapy for Patients with Lung Cancer

on: November 08, 2018In: Radiation Oncology
Living in the “Gray Zone”: Entering a New Age in Radiation Therapy for Patients with Lung
            Cancer

Posted: October 2018 Patients with stage III or more advanced lung cancer tend to be older and less healthy than patients with other stage III cancers. Because of this, selection […] Read more

The Role for Trimodality Therapy in Stage III NSCLC

on: June 01, 2018In: Radiation Oncology
The Role for Trimodality Therapy in Stage III NSCLC

By Leah Lawrence Posted: June 2018 The use of trimodality therapy—the combination of chemoradiotherapy followed by surgery—remains controversial for patients with locally advanced cN2-N3 NSCLC. According to the National Comprehensive […] Read more

Patients with EGFR Mutation Should Postpone Brain Radiation for CNS Metastases: Pro and Con

on: December 18, 2017In: Radiation Oncology
Patients with EGFR Mutation Should Postpone Brain Radiation for CNS Metastases: Pro and Con

By Pranshu Mohindra, MD, MBBS, DABR®, Lecia Sequist, MD, and Laurie E. Gaspar, MD, MBA Posted: December 2017 Since the initial approval of erlotinib, an oral tyrosine kinase inhibitor (TKI), […] Read more

Utility and Controversies Surrounding Use of New Techniques in Radiotherapy

on: December 18, 2017In: Radiation Oncology
Utility and Controversies Surrounding Use of New Techniques in Radiotherapy

By Suresh Senan, MRCP, FRCR, PhD Posted: December 2017 Improved delivery of radiotherapy has contributed to the recent changes in guidelines for patients with lung cancer. The clinical impact of […] Read more

Proton-Beam Therapy Versus Photon-Beam Therapy: The Debate Continues

on: September 28, 2017In: Radiation Oncology
Proton-Beam Therapy Versus Photon-Beam Therapy: The Debate Continues

By Cynthia L. Kryder, MS, CCC-Sp Posted: October 2017 For patients who present with inoperable, locally advanced lung cancer, photon-based chemoradiation remains the standard of care. Despite advanced radiation-delivery techniques, […] Read more

1234
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy